The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells

Abstract Background & aim: Royal jelly, secreted by worker bees, has different biological activities on cells and tissues. The aim of this study was to evaluate the effects of royal jelly on peripheral blood mononuclear cells and on the tumor category of K562 cell line. Methods: In the present...

Full description

Bibliographic Details
Main Authors: SE Hosseini, N Delerezh, N Afzal Ahangaran
Format: Article
Language:fas
Published: Yasuj University Of Medical Sciences 2014-02-01
Series:Armaghane Danesh Bimonthly Journal
Subjects:
Online Access:http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-360&slc_lang=en&sid=1
_version_ 1811253533055385600
author SE Hosseini
N Delerezh
N Afzal Ahangaran
author_facet SE Hosseini
N Delerezh
N Afzal Ahangaran
author_sort SE Hosseini
collection DOAJ
description Abstract Background & aim: Royal jelly, secreted by worker bees, has different biological activities on cells and tissues. The aim of this study was to evaluate the effects of royal jelly on peripheral blood mononuclear cells and on the tumor category of K562 cell line. Methods: In the present experimental study, three subjects were selected separately with three repetitions. K562 (104 cells) and PBMC (105 cells) with different concentrations of royal jelly (5, 10, 25, 50 and 100 mg/ml) were cultured under standard conditions for 48 and 72 h separately. The fatality rate on PBMC cells and K562 cancer cells was evaluated by using MTT (Tetrazolium Dye-Reduction Assay). The number of viable cells in PBMC that were exposed for 48 hours with Royal Jelly was evaluated by trypan blue staining. Data were analyzed by ANOVA. Results: The royal jelly had no cytotoxicity effect on PBMC cells but at concentration of 50 and 100 mg/mL the cytotoxicity effect were observed on k562 cells whereas, at 10 and 25 mg/ml the number of PBMC viable cells increased. Conclusion: Due to the lack of lethality of royal jelly on PBMC cells and PBMC cell viability and an increase in the fatality rate of cancer cells in the future, royal jelly can be used as a potential candidate for treatment of leukemia. Keywords: Royal jelly, K562, peripheral blood mononuclear cell
first_indexed 2024-04-12T16:52:26Z
format Article
id doaj.art-14b20b10cf574b51bb80e2a96ae782c9
institution Directory Open Access Journal
issn 1728-6506
1728-6514
language fas
last_indexed 2024-04-12T16:52:26Z
publishDate 2014-02-01
publisher Yasuj University Of Medical Sciences
record_format Article
series Armaghane Danesh Bimonthly Journal
spelling doaj.art-14b20b10cf574b51bb80e2a96ae782c92022-12-22T03:24:21ZfasYasuj University Of Medical SciencesArmaghane Danesh Bimonthly Journal1728-65061728-65142014-02-011811869878The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear CellsSE Hosseini0N Delerezh1N Afzal Ahangaran2 Abstract Background & aim: Royal jelly, secreted by worker bees, has different biological activities on cells and tissues. The aim of this study was to evaluate the effects of royal jelly on peripheral blood mononuclear cells and on the tumor category of K562 cell line. Methods: In the present experimental study, three subjects were selected separately with three repetitions. K562 (104 cells) and PBMC (105 cells) with different concentrations of royal jelly (5, 10, 25, 50 and 100 mg/ml) were cultured under standard conditions for 48 and 72 h separately. The fatality rate on PBMC cells and K562 cancer cells was evaluated by using MTT (Tetrazolium Dye-Reduction Assay). The number of viable cells in PBMC that were exposed for 48 hours with Royal Jelly was evaluated by trypan blue staining. Data were analyzed by ANOVA. Results: The royal jelly had no cytotoxicity effect on PBMC cells but at concentration of 50 and 100 mg/mL the cytotoxicity effect were observed on k562 cells whereas, at 10 and 25 mg/ml the number of PBMC viable cells increased. Conclusion: Due to the lack of lethality of royal jelly on PBMC cells and PBMC cell viability and an increase in the fatality rate of cancer cells in the future, royal jelly can be used as a potential candidate for treatment of leukemia. Keywords: Royal jelly, K562, peripheral blood mononuclear cellhttp://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-360&slc_lang=en&sid=1Keywords: Royal jelly K562 peripheral blood mononuclear cell
spellingShingle SE Hosseini
N Delerezh
N Afzal Ahangaran
The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
Armaghane Danesh Bimonthly Journal
Keywords: Royal jelly
K562
peripheral blood mononuclear cell
title The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
title_full The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
title_fullStr The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
title_full_unstemmed The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
title_short The Effects of Royal Jelly on In-Vitro Cytotoxicity of K562 Cells and Peripheral Blood Mononuclear Cells
title_sort effects of royal jelly on in vitro cytotoxicity of k562 cells and peripheral blood mononuclear cells
topic Keywords: Royal jelly
K562
peripheral blood mononuclear cell
url http://armaghanj.yums.ac.ir/browse.php?a_code=A-10-1-360&slc_lang=en&sid=1
work_keys_str_mv AT sehosseini theeffectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells
AT ndelerezh theeffectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells
AT nafzalahangaran theeffectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells
AT sehosseini effectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells
AT ndelerezh effectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells
AT nafzalahangaran effectsofroyaljellyoninvitrocytotoxicityofk562cellsandperipheralbloodmononuclearcells